Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-030300

President and CEO sold 18,333 shares at an average $58.64 ($1,075,102)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2021-05-03 Sale −13,997 $58.45 $818,083 2,233,411 I
Watts Ryan J. President and CEO 2021-05-03 Sale −3,485 $59.12 $206,030 2,229,926 I
Watts Ryan J. President and CEO 2021-05-03 Sale −851 $59.92 $50,989 2,229,075 I
Open-market sales · 18,333 sh · avg $58.64 · $1,075,102
Loading xslF345X03/doc4.xml…